These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24469030)

  • 1. Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies.
    Nagel D; Vincendeau M; Eitelhuber AC; Krappmann D
    Oncogene; 2014 Dec; 33(50):5655-65. PubMed ID: 24469030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of NF-κB deregulation in lymphoid malignancies.
    Krappmann D; Vincendeau M
    Semin Cancer Biol; 2016 Aug; 39():3-14. PubMed ID: 27262792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications.
    Jost PJ; Ruland J
    Blood; 2007 Apr; 109(7):2700-7. PubMed ID: 17119127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
    Hosokawa Y
    Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
    Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
    Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
    Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
    Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
    Bargou RC; Emmerich F; Krappmann D; Bommert K; Mapara MY; Arnold W; Royer HD; Grinstein E; Greiner A; Scheidereit C; Dörken B
    J Clin Invest; 1997 Dec; 100(12):2961-9. PubMed ID: 9399941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protein expression and clinical significance of cyclooxygenase 2 and nuclear factor kappa B in gastric mucosa-associated lymphoid tissue lymphoma].
    Wu XL; Han SL; Wan L; Huang KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):163-6. PubMed ID: 18344086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALT lymphoma: many roads lead to nuclear factor-κb activation.
    Du MQ
    Histopathology; 2011 Jan; 58(1):26-38. PubMed ID: 21261681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
    Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
    Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-κB deregulation in splenic marginal zone lymphoma.
    Spina V; Rossi D
    Semin Cancer Biol; 2016 Aug; 39():61-7. PubMed ID: 27503810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
    Bavi P; Uddin S; Bu R; Ahmed M; Abubaker J; Balde V; Qadri Z; Ajarim D; Al-Dayel F; Hussain AR; Al-Kuraya KS
    J Pathol; 2011 Jul; 224(3):355-66. PubMed ID: 21506127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The action mechanisms of unclassical NF-kappaB activity and TRAF3 expression in Hodgkin's lymphoma cells].
    Guo F; Wang WJ; Sun AN; Zhou P; Chen ZX
    Zhonghua Xue Ye Xue Za Zhi; 2009 Oct; 30(10):678-82. PubMed ID: 19954665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
    Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
    Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
    Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
    Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.
    Hamoudi RA; Appert A; Ye H; Ruskone-Fourmestraux A; Streubel B; Chott A; Raderer M; Gong L; Wlodarska I; De Wolf-Peeters C; MacLennan KA; de Leval L; Isaacson PG; Du MQ
    Leukemia; 2010 Aug; 24(8):1487-97. PubMed ID: 20520640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.